Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05JAH
|
|||
| Former ID |
DNC005040
|
|||
| Drug Name |
4-Carbazol-9-yl-butyric acid
|
|||
| Synonyms |
CARBAZOLE BUTANOIC ACID; 4-(9H-CARBAZOL-9-YL)BUTANOIC ACID; CHEMBL185595; CRZ; 90053-09-1; 4-Carbazol-9-yl-butyric acid; 1tow; AC1L9MBO; 4-carbazol-9-ylbutanoic acid; 9H-Carbazole-9-butanoic acid; SCHEMBL4314440; 4-(N-carbazolyl) butyric acid; CTK3I5050; DTXSID50332287; BDBM50152851; AKOS000153937
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H15NO2
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C3=CC=CC=C3N2CCCC(=O)O
|
|||
| InChI |
1S/C16H15NO2/c18-16(19)10-5-11-17-14-8-3-1-6-12(14)13-7-2-4-9-15(13)17/h1-4,6-9H,5,10-11H2,(H,18,19)
|
|||
| InChIKey |
HQAKVYGASUTQHH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 90053-09-1
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid-binding protein 4 (FABP4) | Target Info | Inhibitor | [1] |
| Fatty acid-binding protein 5 (FABP5) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | PPAR signaling pathway | |||
| NetPath Pathway | TCR Signaling Pathway | |||
| IL1 Signaling Pathway | ||||
| Pathway Interaction Database | AP-1 transcription factor network | |||
| Reactome | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |||
| Transcriptional regulation of white adipocyte differentiation | ||||
| WikiPathways | Lipid digestion, mobilization, and transport | |||
| Transcriptional Regulation of White Adipocyte Differentiation | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.